A drug will not function unless it is bound to a receptor: a longstanding confusion in basic pharmacology

Partha S. Saha

Abstract


The disparity between the general definition of a ‘drug’ and the wide-spread mechanism of actions of receptor-dependent drugs may often mislead to believe that a drug-receptor interaction is always indispensable for a drug to exert its action. This short review is intended to rectify this basic misconception in pharmacology with the aid of a list of examples of several receptor-independent drugs in context to their mode of actions.


Keywords


Receptor-independent drugs, Osmotic diuretics, Keratolytic agent, Chelating agents, Surfactants, Antacid, Protectants and adsorbents, Sucralfate, Laxatives, Cholestyramine, NAC

Full Text:

PDF

References


Neubig RR, Spedding M, Kenakin T, Christopoulos A. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology. Pharmacol Rev. 2003 Dec; 55(4):597-606.

World Health Organization (WHO). Lexicon of alcohol and drug terms published by the World Health Organization. 2013. Available at http://www.who.int/substance_abuse/terminology/who_lexicon/en/. Accessed on 28 October 2013.

Jones PJ and MacKay D. Food & Drugs : Are there complementary beneficial effects for health? France: Dardaine-leopoli.2010.p8.

Okoromah CA, Afolabi BB. Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria. Cochrane Database Syst Rev 2004;(4):CD004615.

Huber C, Christophers E. “Keratolytic” effect of salicylic acid. Archives of Dermatological Research 1977; 257(3):293-297

Davies M, Marks R. Studies on the effect of salicylic acid on normal skin. Br J Dermatol 1976; 95(2):187-92.

Konstantinovic P, Wise RD. Effectiveness of wart removal by compositions including propolis. 1996. US5576005A.

Lane CG, Wilson AC, Baugh RF. Platelet function evaluation technique for citrated whole blood. 2001. United States patent: US 62322127 B1.

Hills BA. An alternative view of the role(s) of surfactant and the alveolar model. Journal of Applied Physiology 1999; 87(5):1567-83.

Schurch S, Lee M and Gehr P. Pulmonary surfactant: Surface properties and function of alveolar and airway surfactant. Pure &App Chern 1992; 64(11): 1745.

National Health Service (NHS). Antacid medicines. 2012. Available at http://www.nhs.uk/conditions/antacid-medicines/Pages/Definition.aspx. Accessed on 28 October 2013.

Maton PN, Burton ME. Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use. Drugs 1999; 57(6):855-70.

Gorget C. Sucralfate: development of a new concept of anti-ulcer treatment.Review of its pharmacodynamic properties (abstract). Rev Med Interne 1985 Jun;6(3):313-9.

Nagashima R. Mechanisms of action of sucralfate. J Clin Gastroenterol 1981;3(2):117-27.

Eddlestone SM. Drug Therapies Used in Gastrointestinal Disease. Compendium 2002; 24(6):452-468.

Lüllmann H, Hein L, Mohr K and Bieger D. Color Atlas of Pharmacology 2005.3rd ed. New York: Thieme. p174.

Thompson WG. Cholestyramine. Canadian Medical Association Journal 1971;104:305-309.

Drugs.com. Cholestyramine (Oral route) 2013. Available at http://www.drugs.com/cons/cholestyramine.html. Accessed on 28 October 2013.

Thorn Research Inc. N-acetylcysteine monograph. Alternative Medicine Review 2000;5(5):467-471.